APA (7th ed.) Citation

Zannad, F., Ferreira, J. P., Pocock, S. J., Anker, S. D., Butler, J., Filippatos, G., . . . Packer, M. (2020). SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: A meta-analysis of the EMPEROR-Reduced and DAPA-HF trials. The Lancet (British edition), 396(10254), 819-829. https://doi.org/10.1016/S0140-6736(20)31824-9

Chicago Style (17th ed.) Citation

Zannad, Faiez, et al. "SGLT2 Inhibitors in Patients with Heart Failure with Reduced Ejection Fraction: A Meta-analysis of the EMPEROR-Reduced and DAPA-HF Trials." The Lancet (British Edition) 396, no. 10254 (2020): 819-829. https://doi.org/10.1016/S0140-6736(20)31824-9.

MLA (9th ed.) Citation

Zannad, Faiez, et al. "SGLT2 Inhibitors in Patients with Heart Failure with Reduced Ejection Fraction: A Meta-analysis of the EMPEROR-Reduced and DAPA-HF Trials." The Lancet (British Edition), vol. 396, no. 10254, 2020, pp. 819-829, https://doi.org/10.1016/S0140-6736(20)31824-9.